IP Library Granted Patent US 8,318,748
Granted Patent B2
US 8,318,748 · App. 13/115,462 · Granted Nov 27, 2012

Cathepsin cysteine protease inhibitors

Assignees: Merck, Sharp & Dohme Corp.; Axys Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,318,748
App. No.
13/115,462
Granted
Nov 27, 2012
Kind
B2
Abstract

This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

Claims (647)

1. A method of treating osteoporosis in a mammal in need thereof by administering to the mammal a therapeutically effective amount of a compound of the following chemical formula:

wherein R 1 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl wherein said alkyl and alkenyl groups are optionally substituted with one to six halo, C 3-6 cycloalkyl, —SR 9 , —SR 12 , —SOR 9 , —SOR 12 , —SO 2 R 9 , —SO 2 R 12 , —SO 2 CH(R 12 )(R 11 ), —OR 12 , —OR 9 , —N(R 12 ) 2 , aryl, heteroaryl or heterocyclyl wherein said aryl, heteroaryl and heterocyclyl groups are optionally substituted with one or two substitutents independently selected from C 1-6 alkyl, halo, hydroxyalkyl, hydroxy, alkoxy or keto;

R 2 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl wherein said alkyl and alkenyl groups are optionally substituted with one to six halo, C 3-6 cycloalkyl, —SR 9 , —SR 12 , —SOR 9 , —SOR 12 , —SO 2 R 9 , —SO 2 R 12 , —SO 2 CH(R 12 )(R 11 ), —OR 12 , —OR 9 , —N(R 12 ) 2 , aryl, heteroaryl or heterocyclyl wherein said aryl, heteroaryl and heterocyclyl groups are optionally substituted with one or two substitutents independently selected from C 1-6 alkyl, halo, hydroxyalkyl, hydroxy, alkoxy or keto;

or R 1 and R 2 can be taken together with the carbon atom to which they are attached to form a C 3-8 cycloalkyl or heterocyclyl ring wherein said ring system is optionally substituted with one or two substituents independently selected from C 1-6 alkyl, hydroxyalkyl, haloalkyl, or halo;

R 3 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl wherein said alkyl and alkenyl groups are optionally substituted with C 3-6 cycloalkyl or one to six halo;

R 4 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl wherein said alkyl and alkenyl groups are optionally substituted with C 3-6 cycloalkyl or one to six halo;

or R 3 and R 4 can be taken together with the carbon atom to which they are attached to form a C 3-8 cycloalkyl ring, C 5-8 cycloalkenyl ring, or five to seven membered heterocyclyl wherein said cycloalkyl, cycloalkenyl and heterocyclyl groups are optionally substituted with one or two substitutents independently selected from C 1-6 alkyl, halo, hydroxyalkyl, hydroxy, alkoxy or keto;

R 5 is selected from hydrogen or C 1-6 alkyl substituted with 1-6 halo;

R 6 is aryl, heteroaryl, C 1-6 haloalkyl, arylalkyl or heteroarylalkyl, wherein said aryl, heteroaryl, arylalkyl and heteroarylalkyl groups are optionally substituted with one, two, or three substituents independently selected from halo, C 1-6 alkyl, C 1-6 haloalkyl, C 3-6 cycloalkyl, haloalkoxy, —SR 9 , —SR 12 , —SOR 9 , —SOR 12 , —SO 2 R 9 , —SO 2 R 12 , —SO 2 CH(R 12 )(R 11 ), —OR 12 , —N(R 10 )(R 11 ), cyano, or aryl which is optionally substituted with —SO 2 R 12 ;

each D is independently C 1-3 alkyl, C 2-3 alkenyl, C 2-3 alkynyl, aryl, heteroaryl, C 3-8 cycloalkyl or heterocyclyl wherein each said aryl, heteroaryl, cycloalkyl and heterocyclyl groups, which may be monocyclic or bicyclic, is optionally substituted on either the carbon or the heteroatom with one to five substituents independently selected from C 1-6 alkyl, haloalkyl, halo, keto, alkoxy, —SR 9 , —SR 12 , —OR 9 , —OR 12 , N(R 12 ) 2 , —SO 2 R 9 , or —SO 2 R 10 ;

R 7 is hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 alkyloxy, halo, nitro, cyano, aryl, heteroaryl, C 3-8 cycloalkyl, heterocyclyl, —C(O)OR 10 , —C(O)OSi[CH(CH 3 ) 2 ] 3 , —OR 9 , —OR 10 , —C(O)R 10 , —R 10 C(O)R 9 , —C(O)R 9 , —C(O)N(R a )(R b ), —C(O)N(R 12 )(R 12 ), —C(O)N(R 10 )(R 11 ), —C(R 10 )(R 11 )OH, —SR 12 , —SR 9 , —R 10 SR 9 , —R 9 , —C(R 9 ) 3 , —C(R 10 )(R 11 )N(R 9 ) 2 , —NR 10 C(O)NR 10 S(O) 2 R 9 , —SO 2 R 12 , —SO(R 12 ), —SO 2 R 9 , —SO m N(R c )(R d ), —SO m CH(R 10 )(R 11 ), —SO 2 N(R 10 )C(O)(R 12 ), —SO 2 (R 10 )C(O)N(R 12 ) 2 , —OSO 2 R 10 , —N(R 10 )(R 11 ), —N(R 10 )C(O)N(R 10 )(R 9 ), N(R 10 )CO(R 9 ), —N(R 10 )C(O)R 10 , —N(R 10 )C(O)OR 10 , —N(R 10 )SO 2 (R 10 ), —C(R 10 )(R 11 )NR 10 C(R 10 )(R 11 )R 9 , —C(R 10 )(R 11 )N(R 10 )R 9 , —C(R 10 )(R 11 )N(R 10 )(R 11 ), —C(R 10 )(R 11 )SC(R 10 )(R 11 )(R 9 ), R 10 S—, —C(R a )(R b )NR a C(R a )(R b )(R 9 ), —C(R a )(R b )N(R a )(R b ), —C(R a )(R b )C(R a )(R b )N(R a )(R b ), —C(O)C(R a )(R b )N(R a )(R b ), —C(R a )(R b )N(R a )C(O)R 9 , —C(O)C(R a )(R b )S(R a ), C(R a )(R b )C(O)N(R a )(R b ), —B(OH) 2 , —OCH 2 O— or 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl;

wherein said groups are optionally substituted on either the carbon or the heteroatom with one to five substituents independently selected from C 1-6 alkyl, halo, keto, cyano, haloalkyl, hydroxyalkyl, —OR 9 , —NO 2 , —NH 2 , —NHS(O) 2 R 8 , —R 9 SO 2 R 12 , —SO 2 R 12 , —SO(R 12 ), —SR 12 , —SR 9 , —SO m N(R c )(R d ), —SO m N(R 10 )C(O)(R 12 ), —C(R 10 )(R 11 )N(R 10 )(R 11 ), —C(R 10 )(R 11 )OH, —COOH, —C(R a )(R b )C(O)N(R a )(R b ), —C(O)(R a )(R b ), —N(R 10 )C(R 10 )(R 11 )(R 9 ), —N(R 10 )CO(R 9 ), —NH(CH 2 ) 2 OH, —NHC(O)OR 10 , —Si(CH 3 ) 3 , heterocycyl, aryl or heteroaryl;

R 8 is hydrogen or C 1-6 alkyl;

or R 4 and R 8 or can be taken together with any of the atoms to which they may be attached or are between them to form a 4-10 membered heterocyclyl ring system wherein said ring system, which may be monocyclic or bicyclic, is optionally substituted with one or two substituents independently selected from C 1-6 alkyl, halo, hydroxyalkyl, hydroxy, keto, —OR 10 , —SR 10 or —N(R 10 ) 2 ;

R 9 is selected from the group consisting of hydrogen, aryl, aryl(C 1-4 )alkyl, heteroaryl, heteroaryl(C 1-4 )alkyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl(C 1-4 )alkyl, and heterocyclyl(C 1-4 )alkyl wherein said groups can be optionally substituted with one, two, or three substituents independently selected from halo, alkoxy or —SO 2 R 12 ;

R 10 is hydrogen or C 1-6 alkyl

R 11 is hydrogen or C 1-6 alkyl;

R 12 is hydrogen or C 1-6 alkyl which is optionally substituted with one, two, or three substituents independently selected from halo, alkoxy, cyano, —NR 10 or —SR 10 ;

R a is hydrogen, C 1-6 alkyl, (C 1-6 alkyl)aryl, (C 1-6 alkyl)hydroxyl, —O(C 1-6 alkyl), hydroxyl, halo, aryl, heteroaryl, C 3-8 cycloalkyl, heterocyclyl, wherein said alkyl, aryl, heteroaryl, C 3-8 cycloalkyl and heterocyclyl can be optionally substituted on either the carbon or the heteroatom with one, two, or three substituents independently selected from C 1-6 alkyl or halo;

R b is hydrogen, C 1-6 alkyl, (C 1-6 alkyl)aryl, (C 1-6 alkyl)hydroxyl, alkoxyl, hydroxyl, halo, aryl, heteroaryl, C 3-8 cycloalkyl, heterocyclyl, wherein said alkyl, aryl, heteroaryl, C 3-8 cycloalkyl and heterocyclyl can be optionally substituted on either the carbon or the heteroatom with one, two, or three substituents independently selected from C 1-6 alkyl or halo;

or R a and R b can be taken together with the carbon atom to which they are attached or are between them to form a C 3-8 cycloalkyl ring or C 3-8 heterocyclyl ring wherein said 3-8 membered ring system may be optionally substituted with one or two substituents independently selected from C 1-6 alkyl and halo;

R c is hydrogen or C 1-6 alkyl which is optionally substituted with one, two, or three substituents independently selected from halo or —OR 9 ;

R d is hydrogen or C 1-6 alkyl which is optionally substituted with one, two, or three substituents independently selected from halo or —OR 9 ;

or R c and R d can be taken together with the nitrogen atom to which they are attached or are between them to form a C 3-8 heterocyclyl ring which is optionally substituted with one or two substituents independently selected from C 1-6 alkyl, halo hydroxyalkyl, hydroxy, alkoxy or keto;

n is independently selected from an integer from one to three;

each m is independently selected from an integer from zero to two;

and the pharmaceutically acceptable salts and stereoisomers thereof.

2. The method of claim 1 wherein R 1 is hydrogen and R 2 is hydrogen, or R 1 and R 2 can be taken together with the carbon atom to which they are attached to form a C 3-8 cycloalkyl ring wherein said ring system is optionally substituted with one or two substituents selected from C 1-6 alkyl or halo, and the pharmaceutically acceptable salts and stereoisomers thereof.

3. The method of claim 2 wherein R 3 is C 1-6 alkyl which is optionally substituted with one to six halo and R 4 is hydrogen, and the pharmaceutically acceptable salts and stereoisomers thereof.

4. The method of claim 3 wherein R 3 is n-propyl, isobutyl, 2-fluoro-2-methylpropyl, 2-trifluoromethylpropyl, 3-fluoro-2-(2-fluoromethyl)propyl, 2,2-difluoroethyl, 2,2-difluoropropyl, 3,3,3-trifluoropropyl, or 2,2-dichloroethyl and R 4 is hydrogen; and the pharmaceutically acceptable salts and stereoisomers thereof.

5. The method of claim 3 wherein R 5 is hydrogen and R 6 is aryl or heteroaryl wherein said aryl or heteroaryl are optionally substituted with one, two or three substituents selected from halo or —SO 2 R 12 ; and the pharmaceutically acceptable salts and stereoisomers thereof.

6. The method of claim 3 wherein R 5 is hydrogen and R 6 is C 1-6 haloalkyl; and the pharmaceutically acceptable salts and stereoisomers thereof.

7. The method of claim 6 wherein R 5 is hydrogen and R 6 is trifluoromethyl or 3,3,3,2,2-pentafluoroethyl; and the pharmaceutically acceptable salts and stereoisomers thereof.

8. The method of claim 6 wherein n is two, each D is independently aryl or heteroaryl and R 7 is —SO m CH(R 10 )(R 11 ) or —SO m (R c )(R d ), R c and R d are each independently hydrogen or C 1-6 alkyl; and the pharmaceutically acceptable salts and stereoisomers thereof.

9. The method of claim 1 wherein the compound is selected from:

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(4-fluoro-3-methylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1R)-2,2,2-trifluoro-1-(4-pyridin-3-ylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-pyridin-3-ylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1R)-2,2,2-trifluoro-1-(4-pyridin-4-ylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-pyridin-4-ylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1R)-2,2,2-trifluoro-1-(4-{[4-(2-fluoroethyl)piperazin-1-yl]carbonyl}phenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(4-{[4-(2-fluoroethyl)piperazin-1-yl]carbonyl}phenyl)ethyl]-L-leucinamide;

N 2 -[1-(1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4-(3-hydroxy-3-methylbut-1-ynyl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(3-hydroxy-3-methylbutyl)phenyl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,3,3,3-pentafluoropropyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,3,3,3-pentafluoro-1-(4-pyridin-4-ylphenyl)propyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4′-fluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4-[(1E)-3-hydroxy-3-methylbut-1-enyl]phenyl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]propyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]propyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1-oxidopyridin-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(morpholin-4-ylcarbonyl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-{[methoxy(methyl)amino]carbonyl}phenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-thien-3-ylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(4-methylpyridin-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(5-methylpyridin-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(2′-fluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-1-[4-(3,5-dimethylisoxazol-4-yl)phenyl]-2,2,2-trifluoroethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(hydroxymethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4′-cyano-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-1-(3′,4′-difluoro-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-L-leucinamide;

4′-{1-[1-(Cyanomethyl-carbamoyl)-3-methyl-butylamino]-2,2,2-trifluoro-ethyl}-biphenyl-2-carboxylic acid methyl ester;

4′-{1-[1-(Cyanomethyl-carbamoyl)-3-methyl-butylamino]-2,2,2-trifluoro-ethyl}-biphenyl-3-carboxylic acid methyl ester;

N 1 -(cyanomethyl)-N 2 -[(1S)-1-(3′,4′-dimethoxy-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[2′-(trifluoromethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-1-(3′,4′-dichloro-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(3′-formyl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(2-oxo-2,3-dihydro-1,3-benzothiazol-6-yl)phenyl]ethyl}-L-leucinamide;

N 2 -{(1S)-1-[4-(5-bromopyridin-3-yl)phenyl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(trifluoromethoxy)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1H-indol-4-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-pyrimidin-5-ylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-quinolin-3-ylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;

4′-{1-[1-(Cyanomethyl-carbamoyl)-3-methyl-butylamino]-2,2,2-trifluoro-ethyl}-biphenyl-4-carboxylic acid methyl ester;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-pyrimidin-2-ylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(3-methylpyridin-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(3-furyl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4-[3-(trifluoromethyl)pyridin-2-yl]phenyl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4-[4-(trifluoromethyl)pyridin-2-yl]phenyl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4-[5-(trifluoromethyl)pyridin-2-yl]phenyl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(3′-methoxy-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(3′-methoxy-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 2 -{(1S)-1-[4′-(acetylamino)-3′-fluoro-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(3-methylthien-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(3′-fluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 2 -{(1S)-1-[4-(5-acetylthien-2-yl)phenyl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -[(1S)-1-(3′-acetyl-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[3′-(trifluoromethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(5′-fluoro-2′-methoxy-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-1-(3′,5′-difluoro-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(2′,3′,5′-trifluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

3-(4′-{1-[1-(Cyanomethyl-carbamoyl)-3-methyl-butylamino]-2,2,2-trifluoro-ethyl}-biphenyl-3-yl)-acrylic acid;

N 2 -{(1S)-1-[4-(9-anthryl)phenyl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -[(1S)-1-(4′-benzoyl-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -[(1S)-1-(3′-acetyl-4′-hydroxy-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-1-[2′-(cyanomethyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4′-(methylsulfinyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(4-morpholin-4-ylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1R)-2,2,2-trifluoro-1-[4-(6-methylpyridin-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(6-methylpyridin-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(5-phenylthien-2-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(4-quinolin-8-ylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-pyridin-2-ylphenyl)ethyl]-L-leucinamide;

N 2 -{1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1R)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(morpholin-4-ylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(isopropylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -((1S)-1-{4′-[(acetylamino)sulfonyl]-1,1′-biphenyl-4-yl}-2,2,2-trifluoroethyl)-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[2′-methyl-4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[1-(5-bromothien-2-yl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -[1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

4-(4′-{1-[1-(Cyanomethyl-carbamoyl)-3-methyl-butylamino]-2,2,2-trifluoro-ethyl}-biphenyl-4-yl)-piperazine-1-carboxylic acid tert-butyl ester;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(4′-piperazin-1-yl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -(2,2,2-trifluoro-1-{4′-[4-(2-hydroxyethyl)piperazin-1-yl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -(2,2,2-trifluoro-1-{4′-[4-(2-hydroxy-2-methylpropyl)piperazin-1-yl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -(1-{4-[(dimethylamino)carbonyl]phenyl}-2,2,2-trifluoroethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(4′-piperazin-1-yl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -(1-{4-[(cyclopropylamino)carbonyl]phenyl}-2,2,2-trifluoroethyl)-L-leucinamide;

4-{1-[1-(Cyanomethyl-carbamoyl)-3-methyl-butylamino]-2,2,2-trifluoro-ethyl}-benzoic acid;

N 1 -(cyanomethyl)-N 2 -(2,2,2-trifluoro-1-{4′-[4-(2-fluoroethyl)piperazin-1-yl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -(2,2,2-trifluoro-1-{4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(4-{[4-(2-hydroxy-2-methylpropyl)piperazin-1-yl]carbonyl}phenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(2-methyl-1,3-thiazol-4-yl)phenyl]ethyl}-L-leucinamide;

N 2 -{1-[4-(3-tert-butyl-1,2,4-triazin-5-yl)phenyl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(4-{2-[3-(methylsulfonyl)phenyl]-1,3-thiazol-4-yl}phenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4-[2-(1H-pyrazol-4-yl)-1,3-thiazol-4-yl]phenyl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -(2,2,2-trifluoro-1-{4′-[4-(methylsulfonyl)piperazin-1-yl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 2 -[1-(3-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-3-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(3-pyridin-4-ylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(4′-piperazin-1-yl-1,1′-biphenyl-3-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-3-yl]ethyl}-L-leucinamide;

N-(cyanomethyl)-1-[(2,2,2-trifluoro-1-phenylethyl)amino]cyclohexanecarboxamide;

1-{[1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(cyanomethyl)cyclohexanecarboxamide;

N-(cyanomethyl)-1-{[2,2,2-trifluoro-1-(4′-piperazin-1-yl-1,1′-biphenyl-4-yl)ethyl]amino}cyclohexanecarboxamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(4-piperidin-4-ylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4-(4-pyridin-2-ylpiperazin-1-yl)phenyl]ethyl}-L-leucinamide;

N 2 -[1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-3-cyclopropylalaninamide;

N 1 -(cyanomethyl)-3-cyclopropyl-N 2 -[2,2,2-trifluoro-1-(4-pyridin-4-ylphenyl)ethyl]alaninamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(4′-pyridin-4-yl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1R)-2,2,2-trifluoro-1-(1,3-thiazol-2-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4′-methoxy-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-methoxyphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4′-pyridin-4-yl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-phenoxyphenyl)ethyl]-L-leucinamide;

N 2 [(1S)-1-(4′-bromo-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -{(1S)-1-[4-(4-chloropyridin-3-yl)phenyl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -{(1S)-1-[4′-(acetylamino)-2′-methyl-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(6-methoxypyridin-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(6-methoxypyridin-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4″-(methylsulfonyl)-1,1′:4′,1″-terphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-3-(1-methylcyclopropyl)-L-alaninamide;

N 1 -(cyanomethyl)-3-(1-methylcyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-alaninamide;

N 1 -(cyanomethyl)-3-(1-methylcyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-alaninamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4′-methyl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 2 [(1S)-1-(4′-acetyl-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(hydroxymethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-D-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-D-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4′-(morpholin-4-ylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-D-leucinamide;

N 1 -(cyanomethyl)-N 2 -(2,2,2-trifluoro-1-{4′-[(methylamino)sulfonyl]-1,1′-biphenyl-4-yl}ethyl)-D-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1R)-2,2,2-trifluoro-1-[4-(1-oxidopyridin-4-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4-(1-oxidopyridin-4-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -(2,2,2-trifluoro-1-{4-[6-(1-hydroxy-1-methylethyl)-1-oxidopyridin-3-yl]phenyl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -(2,2,2-trifluoro-1-{4-[6-(methylsulfonyl)pyridin-3-yl]phenyl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -(2,2,2-trifluoro-1-{4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]phenyl}ethyl)-L-leucinamide;

N 2 -[1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(4-piperazin-1-ylphenyl)ethyl]-L-leucinamide;

N 2 -{1-[3′-(acetylamino)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4-(4-propylpiperazin-1-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4-(piperazin-1-ylcarbonyl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trifluoro-1-(4-{[4-(2-hydroxyethyl)piperazin-1-yl]carbonyl}phenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}phenyl)ethyl]-L-leucinamide;

4-{1-[1-(Cyanomethyl-carbamoyl)-3-methyl-butylamino]-2,2,2-trifluoro-ethyl}-benzoic acid methyl ester;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4-[(E)-2-quinolin-2-ylethenyl]phenyl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]ethyl}-L-leucinamide;

N 2 -((1S)-1-{4-[3-(5-bromopyridin-3-yl)-1,2,4-oxadiazol-5-yl]phenyl}-2,2,2-trifluoroethyl)-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -[(1S)-1-(4-benzoylphenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(thien-2-ylcarbonyl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1,3-thiazol-2-ylcarbonyl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-{(Z)-2-[4-(methylsulfonyl)phenyl]ethenyl}phenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-{(E)-2-[4-(methylsulfonyl)phenyl]ethenyl}phenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-isobutyrylphenyl)ethyl]-L-leucinamide;

N 2 -{(1S)-1-[4-(4-bromo-1,3-thiazol-2-yl)phenyl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-1-(4-cyanophenyl)-2,2,2-trifluoroethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-1-(4-ethynylphenyl)-2,2,2-trifluoroethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(2′-fluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4-(2-methylquinolin-7-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4-(1H-indol-5-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{1-[4′-(dimethylamino)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-1-(4-{[(cyanomethyl)amino]carbonyl}phenyl)-2,2,2-trifluoroethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1R)-1-(4-{[(cyanomethyl)amino]carbonyl}phenyl)-2,2,2-trifluoroethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[3′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

4′-{1-[1-(Cyanomethyl-carbamoyl)-3-methyl-butylamino]-2,2,2-trifluoro-ethyl}-biphenyl-4-carboxylic acid;

4′-{1-[1-(Cyanomethyl-carbamoyl)-3-methyl-butylamino]-2,2,2-trifluoro-ethyl}-biphenyl-4-carboxylic acid methoxy-methyl-amide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-({[4-(methylsulfonyl)benzyl]thio}methyl)phenyl]ethyl}-L-leucinamide;

N 2 -{(1S)-1-[4-(5-chloropyridin-2-yl)phenyl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -{(1S)-1-[3′-(aminosulfonyl)-4′-bromo-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -{(1S)-1-[4′-bromo-3′-(methylsulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4-[5-methyl-6-(methylsulfonyl)pyridin-3-yl]phenyl}ethyl)-L-leucinamide;

N 2 -[(1S)-1-(4-{5-chloro-3-[4-(methylsulfonyl)phenyl]pyridin-2-yl}phenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4-[(phenylthio)methyl]phenyl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4′-[(trifluoromethyl)sulfonyl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-{[(4-fluorobenzoyl)amino]methyl}phenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(methylsulfonyl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-1-[4′-(ethylsulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-L-leucinamide;

N 2 -((1S)-1-{4-[({[3-(2-chloro-6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)methyl]phenyl}-2,2,2-trifluoroethyl)-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -((1S)-1-{4-[(9-chloro-3-methyl-4-oxoisoxazolo[4,3-c]quinolin-5(4H)-yl)methyl]phenyl}-2,2,2-trifluoroethyl)-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-methoxy-3′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -{(1S)-1-[4″-chloro-4′-(methylsulfonyl)-1,1′:2′,1″-terphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[2′-methoxy-4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -{(1S)-1-[2′-chloro-4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4′-[(2-hydroxyethyl)thio]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[3′-fluoro-4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4′-[(2-hydroxyethyl)sulfonyl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[3′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-({2-[methoxy(methyl)amino]-2-oxoethyl}sulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4′-[(2-hydroxy-2-methylpropyl)sulfonyl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 2 -{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 2 -[(4-bromophenyl)(2,4,6-trifluorophenyl)methyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(4-pyridin-4-ylphenyl)(2,4,6-trifluorophenyl)methyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[[4-(4-fluorobenzyl)phenyl](phenyl)methyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{phenyl[4-(pyridin-3-ylmethyl)phenyl]methyl}-L-leucinamide;

N 2 -{(4-bromophenyl)[4-(methylsulfonyl)phenyl]methyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{[4-(methylsulfonyl)phenyl][4′-(methylthio)-1,1′-biphenyl-4-yl]methyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl][4-(methylsulfonyl)phenyl]methyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2,2,2-trichloro-1-(4-glycoloylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[2-fluoro-1-(fluoromethyl)-1-phenylethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4-(pyrrolidin-1-ylacetyl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4-(piperazin-1-ylcarbonyl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -(2,2,2-trifluoro-1-{4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]phenyl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-3-(1-methylcyclopropyl)-N 2 -(2,2,2-trifluoro-1-{4-[1-(2-hydroxyethyl)prolyl]phenyl}ethyl)-L-alaninamide;

N 2 -[[4-(4-tert-butylpiperazin-1-yl)phenyl](pentafluorophenyl)methyl]-N 1 -(cyanomethyl)-L-leucinamide;

N-(cyanomethyl)-1-{1-[4-(4-methylpiperazin-1-yl)phenyl]ethyl}piperidine-2-carboxamide;

N 2 -[[4-(4-tert-butylpiperazin-1-yl)phenyl](pyridin-2-yl)methyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -{[4-(4-tert-butylpiperazin-1-yl)phenyl][5-(trifluoromethyl)pyridin-2-yl]methyl}-N 1 -(cyanomethyl)-L-leucinamide;

(4S)—N-(cyanomethyl)-4-methyl-1-[(1S)-1-(4-piperazin-1-ylphenyl)ethyl]-L-prolinamide;

(4S)—N-(cyanomethyl)-4-methyl-1-[(1R)-1-(4-piperazin-1-ylphenyl)ethyl]-L-prolinamide;

N-(cyanomethyl)-1-[(1S)-1-(4-piperazin-1-ylphenyl)ethyl]-L-prolinamide;

N-(cyanomethyl)-1-[(1R)-1-(4-piperazin-1-ylphenyl)ethyl]-L-prolinamide;

N-(cyanomethyl)-4,4-difluoro-1-[(1S)-1-(4-piperazin-1-ylphenyl)ethyl]-L-prolinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-methylphenyl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1H-pyrazol-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(2-methyl-1,3-oxazol-4-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-pyrazin-2-ylphenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(2-methylpyridin-4-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(4-methylpyridin-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1H-pyrazol-4-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-pyridin-4-ylphenyl)ethyl]-L-leucinamide;

N 2 -[(1S)-1-(3′-acetyl-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(3′-fluoro-4′-methyl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -((1S)-2,2,2-trifluoro-1-{5-[4-(1-hydroxy-1-methylethyl)phenyl]pyridin-2-yl}ethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]propyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(1S)-2,2,3,3,3-pentafluoro-1-(4′-methyl-1,1′-biphenyl-4-yl)propyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4-(6-methoxypyridin-3-yl)phenyl]propyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 [(1S)-2,2,3,3,3-pentafluoro-1-(2′-fluoro-1,1′-biphenyl-4-yl)propyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-methoxy-3′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -{(1S)-1-[3′-(aminosulfonyl)-4′-methoxy-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(6-methoxypyridin-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4-(5-methylpyridin-2-yl)phenyl]propyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 ((1S)-2,2,2-trifluoro-1-{4-[5-(methylsulfonyl)pyridin-2-yl]phenyl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(5-methylpyridin-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[2′-methyl-4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[5-(1H-pyrazol-3-yl)pyridin-2-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(5-quinolin-5-ylpyridin-2-yl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(5-quinolin-6-ylpyridin-2-yl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2-difluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4′-acetyl-1,1′-biphenyl-4-yl)-2,2,3,3,3-pentafluoropropyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 2 -[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 2 -{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,3,3,3-pentafluoropropyl}-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(1-ethoxyvinyl)phenyl]-2,2,2-trifluoroethyl}-L-leucinamide;

N 2 -[(1S)-1-(4-acetylphenyl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-isopropylphenyl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(1S)-2,2,2-trifluoro-1-phenylethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1-hydroxy-1-methylethyl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1-methylcyclopropyl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(2′,4′,6′-trimethyl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 2 -[(1S)-1-(6-chloropyridin-3-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 2 -{(1S)-1-[5-(4-acetylphenyl)pyridin-2-yl]-2,2,2-trifluoroethyl}-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 2 -{(1S)-1-[6-(4-acetylphenyl)pyridin-3-yl]-2,2,2-trifluoroethyl}-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 2 -{(1S)-1-[5-(3-acetylphenyl)pyridin-2-yl]-2,2,2-trifluoroethyl}-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -((1S)-2,2,2-trifluoro-1-{5-[4-(1-hydroxyethyl)phenyl]pyridin-2-yl}ethyl)-L-leucinamide;

N 2 -[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,3,3,3-pentafluoropropyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -[(1S)-1-(4′-acetyl-1,1′-biphenyl-4-yl)-2,2,3,3,3-pentafluoropropyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,3,3,3-pentafluoropropyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 2 -(1-benzyl-2,2,2-trifluoroethyl)-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 2 -[(1S)-1-(4-tert-butylphenyl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-4-methyl-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-4-methyl-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4-[2-(1H-pyrazol-4-yl)-1,3-thiazol-4-yl]phenyl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(2-methyl-1,3-thiazol-4-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(2-methylpyridin-4-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(2-methylpyridin-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(6-methylpyridin-2-yl)phenyl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(3′-acetyl-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1H-pyrazol-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -[(1S)-1-cyanoethyl]-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -[(1S)-1-cyano-3-(methylthio)propyl]-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -[(1S)-1-cyano-3-(methylsulfonyl)propyl]-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,3,3,3-pentafluoropropyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4-(6-methoxypyridin-2-yl)phenyl]propyl}-L-leucinamide;

N 2 -[(1S)-1-(5-bromopyridin-2-yl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,2-trifluoro-1-{5-[4-(methylsulfonyl)phenyl]pyridin-2-yl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(6′-methyl-3,3′-bipyridin-6-yl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(6-methoxypyridin-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(6-oxo-1,6-dihydropyridin-2-yl)phenyl]ethyl}-L-leucinamide;

(4S)—N 1 -(cyanomethyl)-5,5,5-trifluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

(4S)—N 1 -(1-cyanocyclopropyl)-5,5,5-trifluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

(4S)—N 1 -(cyanomethyl)-5,5,5-trifluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

(4S)—N 1 -(1-cyanocyclopropyl)-5,5,5-trifluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

(4S)—N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-5,5,5-trifluoro-L-leucinamide;

(4S)—N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-5,5,5-trifluoro-L-leucinamide;

N 2 -{(1S)-1-[4-(6-aminopyridin-3-yl)phenyl]-2,2,2-trifluoroethyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4-(6-methylpyridin-3-yl)phenyl]propyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4-(6-methylpyridin-3-yl)phenyl]propyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(6-methylpyridin-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(2,2,2-trifluoro-1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]propyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]propyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]propyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4-(6-methoxypyridin-2-yl)phenyl]propyl}-L-leucinamide;

(4R)—N 1 -(cyanomethyl)-5,5,5-trifluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

(4R)—N 1 -(1-cyanocyclopropyl)-5,5,5-trifluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(1S)-2,2,3,3,3-pentafluoro-1-(4′-methyl-1,1′-biphenyl-4-yl)propyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4-(1,3-thiazol-2-yl)phenyl]propyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(1S)-1-(4-ethynylphenyl)-2,2,3,3,3-pentafluoropropyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-1-[4-(cyclopropylethynyl)phenyl]-2,2,2-trifluoroethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(cyclopropylethynyl)phenyl]-2,2,2-trifluoroethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(5-methyl-1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(5-methyl-1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(cyclopropylethynyl)phenyl]-2,2,3,3,3-pentafluoropropyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(4-methyl-1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(4-methyl-1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-1-[4-(4,5-dimethyl-1,3-thiazol-2-yl)phenyl]-2,2,2-trifluoroethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4′-(ethylsulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4-pyridin-3-ylphenyl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-methoxy-3′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-alaninamide;

N 2 -{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,3,3,3-pentafluoropropyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((1S)-2,2,3,3,3-pentafluoro-1-{4′-[(2-hydroxy-2-methylpropyl)sulfonyl]-1,1′-biphenyl-4-yl}propyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-alaninamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,3,3,3-pentafluoro-1-[4′-(isopropylsulfonyl)-1,1′-biphenyl-4-yl]propyl}-L-leucinamide;

N 1 -(1-cyano-1-methylethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -((1S)-2,2,2-trifluoro-1-{4′-[(2-hydroxy-2-methylpropyl)sulfonyl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[2′-methyl-4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4′-(ethylsulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-L-leucinamide;

N 2 -{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(S)-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl][4-(trifluoromethoxy)phenyl]methyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(S)-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl](thien-2-yl)methyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(S)-(4′-piperazin-4-ium-1-yl-1,1′-biphenyl-4-yl)(thien-2-yl)methyl]-L-leucinamide methanesulfonate;

N 1 -(cyanomethyl)-N 2 -{(S)-(4-fluorophenyl)[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]methyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(S)-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl][4-(trifluoromethyl)phenyl]methyl}-L-leucinamide;

N 2 -{(S)-(4-chlorophenyl)[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]methyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 2 -[(S)-(4-bromophenyl)(thien-2-yl)methyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(S)-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl](thien-2-yl)methyl]-L-leucinamide;

N 2 -{(R)-(4-bromophenyl)[4-(trifluoromethoxy)phenyl]methyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(S)-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl][4-(trifluoromethoxy)phenyl]methyl}-L-leucinamide;

N 2 -[(S)-(4-bromophenyl)(2-furyl)methyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(S)-2-furyl[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]methyl}-L-leucinamide;

N 2 -[1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-L-norvalinamide;

N 2 -{(R)-(4-bromophenyl)[4-(trifluoromethyl)phenyl]methyl}-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{1-[4′-(4-cyclopropylpiperazin-1-yl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-L-norvalinamide;

N 2 -[(R)-(4-bromophenyl)(4-chlorophenyl)methyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 2 -[(S)-(4-bromophenyl)(3-methylthien-2-yl)methyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -[(S)-(4-bromophenyl)(thien-3-yl)methyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(S)-(2,4-difluorophenyl)[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]methyl}-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(S)-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl](thien-3-yl)methyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(S)-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl](3-methylthien-2-yl)methyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(S)-[4′-(4-cyclopropylpiperazin-1-yl)-1,1′-biphenyl-4-yl](3-methylthien-2-yl)methyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -[(S)-[4′-(4-cyclopropylpiperazin-1-yl)-1,1′-biphenyl-4-yl](thien-3-yl)methyl]-L-leucinamide;

N 2 -[1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-5,5,5-trifluoro-L-norvalinamide;

N 1 -(cyanomethyl)-5,5,5-trifluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 2 -[(S)-(4-bromophenyl)(3-methylthien-2-yl)methyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(S)-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl](3-methylthien-2-yl)methyl]-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -{(S)-3-furyl[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]methyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-norvalinamide N 2 -[(S)-(4-bromophenyl)(4-bromothien-2-yl)methyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 2 -[(S)-(4-bromophenyl)(thien-3-yl)methyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(cyanomethyl)-N 2 -((S)-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]{4-[4-(methylsulfonyl)phenyl]thien-2-yl}methyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(S)-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl](thien-3-yl)methyl]-L-leucinamide;

N 2 -{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 -(1-cyanocyclopropyl)-L-norvalinamide;

N 2 -[(S)-(4-bromophenyl)(4-bromothien-2-yl)methyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 2 -[(S)-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl](thien-3-yl)methyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 2 -[(S)-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl](thien-3-yl)methyl]-N 1 -(cyanomethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-methoxy-3′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(2-methylpyridin-4-yl)phenyl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-5,5,5-trifluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1H-pyrazol-3-yl)phenyl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(5-methylpyridin-2-yl)phenyl]ethyl}-L-norvalinamide;

2-{[(4-Bromo-phenyl)-pyridin-4-yl-methyl]-amino}-pentanoic acid cyanomethyl-amide;

2-{[(4-Bromo-phenyl)-thiazol-2-yl-methyl]-amino+}-pentanoic acid cyanomethyl-amide;

(2S)-2-[(S)-1-(4′-Acetylbiphenyl-4-yl)-2,2,2-trifluoroethylamino]-pentanoic acid(1-cyanocyclopropyl)-amide;

(2S)-2-[(S)-1-(2′,4′-Difluorobiphenyl-4-yl)-2,2,2-trifluoroethylamino]-pentanoic acid(1-cyanocyclopropyl)-amide;

(2S)-2-[(S)-1-(3′,4′-Difluorobiphenyl-4-yl)-2,2,2-trifluoroethylamino]-pentanoic acid(1-cyanocyclopropyl)-amide;

(2S)-2-[(S)-1-(3′-Chloro-4′-fluorobiphenyl-4-yl)-2,2,2-trifluoroethylamino]-pentanoic acid(1-cyano-cyclopropyl)-amide;

(2S)-2-[(S)-2,2,2-Trifluoro-1-(4′-methanesulfonylamino-biphenyl-4-yl)-ethylamino]-pentanoic acid(1-cyano-cyclopropyl)-amide;

(2S)-2-{(S)-[(4-Bromo-phenyl)-thiazol-2-yl-methyl]-amino}-4-methylpentanoic acid cyanomethyl-amide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-chloro-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-chloro-3′-methyl-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-chloro-2′-methyl-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

(2S)-2-{(S)-2,2,2-Trifluoro-1-[4-(1H-indol-5-yl)-phenyl]-ethylamino}-pentanoic acid(1-cyano-cyclopropyl)-amide;

(2S)-2-[(S)-2,2,2-Trifluoro-1-(3′-methanesulfonylamino-biphenyl-4-yl)-ethylamino]-pentanoic acid(1-cyano-cyclopropyl)-amide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-fluoro-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-fluoro-3′-methyl-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[3′-fluoro-4′-methyl-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-trifluoromethoxy-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

(2S)-2-[(S)-2,2,2-Trifluoro-1-(4′-methylbiphenyl-4-yl)-ethylamino]-pentanoic acid(1-cyanocyclopropyl)-amide;

(2S)-2-[(S)-1-(4′-Cyanobiphenyl-4-yl)-2,2,2-trifluoroethylamino]-pentanoic acid(1-cyanocyclopropyl)-amide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-methoxy-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(benzo[1,3]dioxol-5-yl)phenyl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methoxycarbonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

(2S)-2-{(S)-[(4-Bromophenyl)-thiazol-2-yl-methyl]-amino}-4-methylpentanoic acid(1-cyanocyclopropyl)-amide;

(2S)-2-{(S)-[(4′-Methanesulfonyl-biphenyl-4-yl)-thiazol-2-yl-methyl]-amino}-4-methyl-pentanoic acid cyanomethyl-amide;

(2S)-2-[(S)-2,2,2-Trifluoro-1-(4′-trifluoromethyl-biphenyl-4-yl)-ethylamino]-pentanoic acid(1-cyano-cyclopropyl)-amide;

(2S)-2-[(S)-2,2,2-Trifluoro-1-(2′-trifluoromethyl-biphenyl-4-yl)-ethylamino]-pentanoic acid(1-cyano-cyclopropyl)-amide;

(2S)-2-{(S)-[(2′,4′-Difluorobiphenyl-4-yl)-thiazol-2-yl-methyl]-amino}-4-methylpentanoic acid(1-cyanocyclopropyl)-amide;

(2S)-2-{(S)-[(4′-Methanesulfonylbiphenyl-4-yl)-thiazol-2-yl-methyl]-amino}-4-methylpentanoic acid(1-cyanocyclopropyl)-amide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1-oxido-2,3-dihydro-1-benzothien-5-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(1,1-dioxido-2,3-dihydro-1-benzothien-5-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(1,1-dioxido-2,3-dihydro-1,2-benzisothiazol-5-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfinyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(1,1-dioxido-3-oxo-2,3-dihydro-1,2-benzisothiazol-5-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[2′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(cyanomethyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(cyanomethyl)-4-fluoro-N 2 -{(1S)-2,2,2-trichloro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trichloro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trichloro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(cyanomethyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trichloro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

(2S)—N-(cyanomethyl)-4,4-difluoro-2-({(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}amino)butanamide;

(2S)—N-(1-cyanocyclopropyl)-4,4-difluoro-2-({(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}amino)butanamide;

(2S)—N-(1-cyanocyclopropyl)-4,4-difluoro-2-({(1S)-2,2,2-trichloro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}amino)butanamide;

(2S)—N-(cyanomethyl)-4,4-difluoro-2-({(1S)-2,2,2-trichloro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}amino)butanamide;

(2S)-4,4-dichloro-N-(cyanomethyl)-2-({(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}amino)butanamide;

(2S)-4,4-dichloro-N-(1-cyanocyclopropyl)-2-({(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}amino)butanamide;

(2S)-4,4-dichloro-N-(1-cyanocyclopropyl)-2-({(1S)-2,2,2-trichloro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}amino)butanamide;

(2S)-4,4-dichloro-N-(cyanomethyl)-2-({(1S)-2,2,2-trichloro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}amino)butanamide;

N 2 -[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[3′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4′-methyl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[3′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4′-acetyl-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;

N 2 -[(1S)-1-(2′-acetyl-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[2′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[2′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -((1S)-2,2,2-trifluoro-1-{5-[4-(methylsulfonyl)phenyl]pyridin-2-yl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -((1S)-2,2,2-trifluoro-1-{6-[4-(methylsulfonyl)phenyl]pyridin-3-yl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4-{6-[(methylsulfonyl)amino]pyridin-3-yl}phenyl)ethyl]-L-leucinamide;

N 1 -(cyanomethyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4-{6-[(methylsulfonyl)amino]pyridin-3-yl}phenyl)ethyl]-L-leucinamide;

N 1 -(1-cyanobutyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyano-2-cyclopropylethyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyano-2-pyridin-3-ylethyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyano-3-hydroxy-3-methylbutyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(1-oxo-1,3-dihydro-2-benzofuran-5-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(3,3-dimethyl-1-oxo-1,3-dihydro-2-benzofuran-5-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(3,3-diethyl-1-oxo-1,3-dihydro-2-benzofuran-5-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(3-oxo-1,3-dihydro-2-benzofuran-5-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(1,1-dimethyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(1,1-diethyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(3-oxo-1,3-dihydro-2-benzofuran-5-yl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4′-(1,1-dimethyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4′-(1,1-diethyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(1-oxo-1,3-dihydro-2-benzofuran-5-yl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4′-(3,3-dimethyl-1-oxo-1,3-dihydro-2-benzofuran-5-yl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4′-(3,3-diethyl-1-oxo-1,3-dihydro-2-benzofuran-5-yl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(5-oxo-2,5-dihydrofuran-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(2,2-dimethyl-5-oxo-2,5-dihydrofuran-3-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4(2,2-diethyl-5-oxo-2,5-dihydrofuran-3-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(2-oxo-2,5-dihydrofuran-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4(5,5-dimethyl-2-oxo-2,5-dihydrofuran-3-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4(5,5-diethyl-2-oxo-2,5-dihydrofuran-3-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(5-oxo-4-oxaspiro[2.4]hept-6-en-7-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(6-oxo-5-oxaspiro[3.4]oct-7-en-8-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(5-oxo-4-oxaspiro[2.4]hept-6-en-6-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(6-oxo-5-oxaspiro[3.4]oct-7-en-7-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4-quinolin-6-ylphenyl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfinyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4′-acetyl-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-quinolin-6-ylphenyl)ethyl]-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-4,4-difluoro-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -[(1S)-1-cyano-3-(methylsulfonyl)propyl]-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4-quinolin-6-ylphenyl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfinyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4′-acetyl-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-quinolin-6-ylphenyl)ethyl]-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-4,4-difluoro-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -((1S)-2,2,2-trifluoro-1-{4-[5-methyl-6-(methylsulfonyl)pyridin-3-yl]phenyl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -((1S)-2,2,2-trifluoro-1-{4-[6-(1-hydroxy-1-methylethyl)-5-methylpyridin-3-yl]phenyl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4′-fluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[3′-methyl-4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(6-methylpyridin-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(2-methylquinolin-7-yl)phenyl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-4,4-difluoro-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -((1S)-2,2,2-trifluoro-1-{4′-[(1S)-1-hydroxyethyl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -((1S)-2,2,2-trifluoro-1-{4′-[(1R)-1-hydroxyethyl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(trifluoroacetyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[5-(2-naphthyl)pyridin-2-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(cyanomethyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(5-methyl-1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(1,1-dioxido-3-oxo-2,3-dihydro-1,2-benzisothiazol-5-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 2 -[(4-bromophenyl)(phenyl)methyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4′-methyl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 2 -[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;

N 2 -{(1S)-1-[4-(5-chloropyridin-2-yl)phenyl]-2,2,2-trifluoroethyl}-N 1 -(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4-pyridin-4-ylphenyl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -((1S)-2,2,2-trifluoro-1-{4′-[(methylsulfonyl)amino]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2-difluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2-difluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4-pyrimidin-5-ylphenyl)ethyl]-L-leucinamide;

N 2 -[(1S)-1-(4′-acetyl-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[3′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4′-acetyl-1,1′-biphenyl-4-yl)-2,2-difluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(3,5-dimethylisoxazol-4-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 1 -[(1S)-1-cyano-3-(methylsulfonyl)propyl]-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4-quinolin-6-ylphenyl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfinyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4′-acetyl-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -[(1S)-2,2,2-trifluoro-1-(4-quinolin-6-ylphenyl)ethyl]-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-4,4-difluoro-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -((1S)-2,2,2-trifluoro-1-{4-[5-methyl-6-(methylsulfonyl)pyridin-3-yl]phenyl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -((1S)-2,2,2-trifluoro-1-{4-[6-(1-hydroxy-1-methylethyl)-5-methylpyridin-3-yl]phenyl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4′-fluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[3′-methyl-4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(6-methylpyridin-3-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(2-methylquinolin-7-yl)phenyl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N 1 -(cyanomethyl)-4,4-difluoro-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -((1S)-2,2,2-trifluoro-1-{4′-[(1S)-1-hydroxyethyl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -((1S)-2,2,2-trifluoro-1-{4′-[(1R)-1-hydroxyethyl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(trifluoroacetyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2,2-trifluoro-1-[5-(2-naphthyl)pyridin-2-yl]ethyl}-L-leucinamide;

N 1 -(cyanomethyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(cyanomethyl)-4,4-difluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4-(5-methyl-1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(1,1-dioxido-3-oxo-2,3-dihydro-1,2-benzisothiazol-5-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

N 2 -[(4-bromophenyl)(phenyl)methyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4′-methyl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;

N 2 -[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;

N 2 -{(1S)-1-[4-(5-chloropyridin-2-yl)phenyl]-2,2,2-trifluoroethyl}-N 1 -(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4-pyridin-4-ylphenyl)ethyl]-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -((1S)-2,2,2-trifluoro-1-{4′-[(methylsulfonyl)amino]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;

N 2 -[(1S)-1-(4-bromophenyl)-2,2-difluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-2,2-difluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -[(1S)-2,2,2-trifluoro-1-(4-pyrimidin-5-ylphenyl)ethyl]-L-leucinamide;

N 2 -[(1S)-1-(4′-acetyl-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N 1 -(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[3′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;

N 2 -[(1S)-1-(4′-acetyl-1,1′-biphenyl-4-yl)-2,2-difluoroethyl]-N 1 -(1-cyanocyclopropyl)-L-leucinamide;

N 1 -(1-cyanocyclopropyl)-N 2 -{(1S)-1-[4-(3,5-dimethylisoxazol-4-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;

and the pharmaceutically acceptable salts and stereoisomers thereof.

10. The method of claim 1 wherein the compound is N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide or a pharmaceutically acceptable salt thereof.

11. The method of claim 1 wherein the compound is N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfinyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide or a pharmaceutically acceptable salt thereof.

12. The method of claim 1 wherein the compound is N 1 (cyanomethyl)-N 2 {(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide or a pharmaceutically acceptable salt thereof.

13. The method of claim 1 wherein the compound is N 2 {(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N 1 (cyanomethyl)-L-leucinamide or a pharmaceutically acceptable salt thereof.

14. The method of claim 1 further comprising another agent selected from the group consisting of: an organic bisphosphonate, an estrogen receptor modulator, an androgen receptor modulator, an inhibitor of osteoclast proton ATPase, an inhibitor of HMG-CoA reductase, an integrin receptor antagonist, or an osteoblast anabolic agent, and the pharmaceutically acceptable salts and mixtures thereof.

15. A method of inhibiting bone resorption in a mammal in need thereof by administering to the mammal a therapeutically effective amount of a compound of the following chemical formula:

wherein R 1 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl wherein said alkyl and alkenyl groups are optionally substituted with one to six halo, C 3-6 cycloalkyl, —SR 9 , —SR 12 , —SOR 9 , —SOR 12 , —SO 2 R 9 , —SO 2 R 12 , —SO 2 CH(R 12 )(R 11 ), —OR 12 , —OR 9 , —N(R 12 ) 2 , aryl, heteroaryl or heterocyclyl wherein said aryl, heteroaryl and heterocyclyl groups are optionally substituted with one or two substitutents independently selected from C 1-6 alkyl, halo, hydroxyalkyl, hydroxy, alkoxy or keto;

R 2 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl wherein said alkyl and alkenyl groups are optionally substituted with one to six halo, C 3-6 cycloalkyl, —SR 9 , —SR 12 , —SOR 9 , —SOR 12 , —SO 2 R 9 , —SO 2 R 12 , —SO 2 CH(R 12 )(R 11 ), —OR 12 , —OR 9 , —N(R 12 ) 2 , aryl, heteroaryl or heterocyclyl wherein said aryl, heteroaryl and heterocyclyl groups are optionally substituted with one or two substitutents independently selected from C 1-6 alkyl, halo, hydroxyalkyl, hydroxy, alkoxy or keto;

or R 1 and R 2 can be taken together with the carbon atom to which they are attached to form a C 3-8 cycloalkyl or heterocyclyl ring wherein said ring system is optionally substituted with one or two substituents independently selected from C 1-6 alkyl, hydroxyalkyl, haloalkyl, or halo;

R 3 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl wherein said alkyl and alkenyl groups are optionally substituted with C 3-6 cycloalkyl or one to six halo;

R 4 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl wherein said alkyl and alkenyl groups are optionally substituted with C 3-6 cycloalkyl or one to six halo;

or R 3 and R 4 can be taken together with the carbon atom to which they are attached to form a C 3-8 cycloalkyl ring, C 5-8 cycloalkenyl ring, or five to seven membered heterocyclyl wherein said cycloalkyl, cycloalkenyl and heterocyclyl groups are optionally substituted with one or two substitutents independently selected from C 1-6 alkyl, halo, hydroxyalkyl, hydroxy, alkoxy or keto;

R 5 is selected from hydrogen or C 1-6 alkyl substituted with 1-6 halo;

R 6 is aryl, heteroaryl, C 1-6 haloalkyl, arylalkyl or heteroarylalkyl, wherein said aryl, heteroaryl, arylalkyl and heteroarylalkyl groups are optionally substituted with one, two, or three substituents independently selected from halo, C 1-6 alkyl, C 1-6 haloalkyl, C 3-6 cycloalkyl, haloalkoxy, —SR 9 , —SR 12 , —SOR 9 , —SOR 12 , —SO 2 R 9 , —SO 2 R 12 , —SO 2 CH(R 12 )(R 11 ), —OR 12 , —N(R 10 )(R 11 ), cyano, or aryl which is optionally substituted with —SO 2 R 12 ;

each D is independently C 1-3 alkyl, C 2-3 alkenyl, C 2-3 alkynyl, aryl, heteroaryl, C 3-8 cycloalkyl or heterocyclyl wherein each said aryl, heteroaryl, cycloalkyl and heterocyclyl groups, which may be monocyclic or bicyclic, is optionally substituted on either the carbon or the heteroatom with one to five substituents independently selected from C 1-6 alkyl, haloalkyl, halo, keto, alkoxy, —SR 9 , —SR 12 , —OR 9 , —OR 12 , N(R 12 ) 2 , —SO 2 R 9 , or —SO 2 R 10 ;

R 7 is hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 alkyloxy, halo, nitro, cyano, aryl, heteroaryl, C 3-8 cycloalkyl, heterocyclyl, —C(O)OR 10 , —C(O)OSi[CH(CH 3 ) 2 ] 3 , —OR 9 , —OR 10 , —C(O)R 10 , —R 10 C(O)R 9 , —C(O)R 9 , —C(O)N(R a )(R b ), —C(O)N(R 12 )(R 12 ), —C(O)N(R 10 )(R 11 ), —C(R 10 )(R 11 )OH, —SR 12 , —SR 9 , —R 10 SR 9 , —R 9 , —C(R 9 ) 3 , —C(R 10 )(R 11 )N(R 9 ) 2 , —NR 10 C(O)NR 10 S(O) 2 R 9 , —SO 2 R 12 , —SO(R 12 ), —SO 2 R 9 , —SO m N(R c )(R d ), —SO m CH(R 10 )(R 11 ), —SO 2 N(R 10 )C(O)(R 12 ), —SO 2 (R 10 )C(O)N(R 12 ) 2 , —OSO 2 R 10 , —N(R 10 )(R 11 ), —N(R 10 )C(O)N(R 10 )(R 9 ), N(R 10 )CO(R 9 ), —N(R 10 )C(O)R 10 , —N(R 10 )C(O)OR 10 , —N(R 10 )SO 2 (R 10 ), —C(R 10 )(R 11 )NR 10 C(R 10 )(R 11 )R 9 , —C(R 10 )(R 11 )N(R 10 )R 9 , —C(R 10 )(R 11 )N(R 10 )(R 11 ), —C(R 10 )(R 11 )SC(R 10 )(R 11 )(R 9 ), R 10 S—, —C(R a )(R b )NR a C(R a )(R b )(R 9 ), —C(R a )(R b )N(R a )(R b ), —C(R a )(R b )C(R a )(R b )N(R a )(R b ), —C(O)C(R a )(R b )N(R a )(R b ), —C(R a )(R b )N(R a )C(O)R 9 , —C(O)C(R a )(R b )S(R a ), C(R a )(R b )C(O)N(R a )(R b ), —B(OH) 2 , —OCH 2 O— or 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl;

wherein said groups are optionally substituted on either the carbon or the heteroatom with one to five substituents independently selected from C 1-6 alkyl, halo, keto, cyano, haloalkyl, hydroxyalkyl, —OR 9 , —NO 2 , —NH 2 , —NHS(O) 2 R 8 , —R 9 SO 2 R 12 , —SO 2 R 12 , —SO(R 12 ), —SR 12 , —SR 9 , —SO m N(R c )(R d ), —SO m N(R 10 )C(O)(R 12 ), —C(R 10 )(R 11 )N(R 10 )(R 11 ), —C(R 10 )(R 11 )OH, —COOH, —C(R a )(R b )C(O)N(R a )(R b ), —C(O)(R a )(R b ), —N(R 10 )C(R 10 )(R 11 )(R 9 ), —N(R 10 )CO(R 9 ), —NH(CH 2 ) 2 OH, —NHC(O)OR 10 , —Si(CH 3 ) 3 , heterocycyl, aryl or heteroaryl;

R 8 is hydrogen or C 1-6 alkyl;

or R 4 and R 8 or can be taken together with any of the atoms to which they may be attached or are between them to form a 4-10 membered heterocyclyl ring system wherein said ring system, which may be monocyclic or bicyclic, is optionally substituted with one or two substituents independently selected from C 1-6 alkyl, halo, hydroxyalkyl, hydroxy, keto, —OR 10 , —SR 10 or —N(R 10 ) 2 ;

R 9 is selected from the group consisting of hydrogen, aryl, aryl(C 1-4 )alkyl, heteroaryl, heteroaryl(C 1-4 )alkyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl(C 1-4 )alkyl, and heterocyclyl(C 1-4 )alkyl wherein said groups can be optionally substituted with one, two, or three substituents independently selected from halo, alkoxy or —SO 2 R 12 ;

R 10 is hydrogen or C 1-6 alkyl

R 11 is hydrogen or C 1-6 alkyl;

R 12 is hydrogen or C 1-6 alkyl which is optionally substituted with one, two, or three substituents independently selected from halo, alkoxy, cyano, —NR 10 or —SR 10 ;

R a is hydrogen, C 1-6 alkyl, (C 1-6 alkyl)aryl, (C 1-6 alkyl)hydroxyl, —O(C 1-6 alkyl), hydroxyl, halo, aryl, heteroaryl, C 3-8 cycloalkyl, heterocyclyl, wherein said alkyl, aryl, heteroaryl, C 3-8 cycloalkyl and heterocyclyl can be optionally substituted on either the carbon or the heteroatom with one, two, or three substituents independently selected from C 1-6 alkyl or halo;

R b is hydrogen, C 1-6 alkyl, (C 1-6 alkyl)aryl, (C 1-6 alkyl)hydroxyl, alkoxyl, hydroxyl, halo, aryl, heteroaryl, C 3-8 cycloalkyl, heterocyclyl, wherein said alkyl, aryl, heteroaryl, C 3-8 cycloalkyl and heterocyclyl can be optionally substituted on either the carbon or the heteroatom with one, two, or three substituents independently selected from C 1-6 alkyl or halo;

or R a and R b can be taken together with the carbon atom to which they are attached or are between them to form a C 3-8 cycloalkyl ring or C 3-8 heterocyclyl ring wherein said 3-8 membered ring system may be optionally substituted with one or two substituents independently selected from C 1-6 alkyl and halo;

R c is hydrogen or C 1-6 alkyl which is optionally substituted with one, two, or three substituents independently selected from halo or —OR 9 ;

R d is hydrogen or C 1-6 alkyl which is optionally substituted with one, two, or three substituents independently selected from halo or —OR 9 ;

or R c and R d can be taken together with the nitrogen atom to which they are attached or are between them to form a C 3-8 heterocyclyl ring which is optionally substituted with one or two substituents independently selected from C 1-6 alkyl, halo hydroxyalkyl, hydroxy, alkoxy or keto;

n is independently selected from an integer from one to three;

each m is independently selected from an integer from zero to two;

and the pharmaceutically acceptable salts and stereoisomers thereof.

16. A method of increasing bone mineral density in a mammal in need thereof by administering to the mammal a therapeutically effective amount of a compound of the following chemical formula:

wherein R 1 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl wherein said alkyl and alkenyl groups are optionally substituted with one to six halo, C 3-6 cycloalkyl, —SR 9 , —SR 12 , —SOR 9 , —SOR 12 , —SO 2 R 9 , —SO 2 R 12 , —SO 2 CH(R 12 )(R 11 ), —OR 12 , —OR 9 , —N(R 12 ) 2 , aryl, heteroaryl or heterocyclyl wherein said aryl, heteroaryl and heterocyclyl groups are optionally substituted with one or two substitutents independently selected from C 1-6 alkyl, halo, hydroxyalkyl, hydroxy, alkoxy or keto;

R 2 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl wherein said alkyl and alkenyl groups are optionally substituted with one to six halo, C 3-6 cycloalkyl, —SR 9 , —SR 12 , —SOR 9 , —SOR 12 , —SO 2 R 9 , —SO 2 R 12 , —SO 2 CH(R 12 )(R 11 ), —OR 12 , —OR 9 , —N(R 12 ) 2 , aryl, heteroaryl or heterocyclyl wherein said aryl, heteroaryl and heterocyclyl groups are optionally substituted with one or two substitutents independently selected from C 1-6 alkyl, halo, hydroxyalkyl, hydroxy, alkoxy or keto;

or R 1 and R 2 can be taken together with the carbon atom to which they are attached to form a C 3-8 cycloalkyl or heterocyclyl ring wherein said ring system is optionally substituted with one or two substituents independently selected from C 1-6 alkyl, hydroxyalkyl, haloalkyl, or halo;

R 3 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl wherein said alkyl and alkenyl groups are optionally substituted with C 3-6 cycloalkyl or one to six halo;

R 4 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl wherein said alkyl and alkenyl groups are optionally substituted with C 3-6 cycloalkyl or one to six halo;

or R 3 and R 4 can be taken together with the carbon atom to which they are attached to form a C 3-8 cycloalkyl ring, C 5-8 cycloalkenyl ring, or five to seven membered heterocyclyl wherein said cycloalkyl, cycloalkenyl and heterocyclyl groups are optionally substituted with one or two substitutents independently selected from C 1-6 alkyl, halo, hydroxyalkyl, hydroxy, alkoxy or keto;

R 5 is selected from hydrogen or C 1-6 alkyl substituted with 1-6 halo;

R 6 is aryl, heteroaryl, C 1-6 haloalkyl, arylalkyl or heteroarylalkyl, wherein said aryl, heteroaryl, arylalkyl and heteroarylalkyl groups are optionally substituted with one, two, or three substituents independently selected from halo, C 1-6 alkyl, C 1-6 haloalkyl, C 3-6 cycloalkyl, haloalkoxy, —SR 9 , —SR 12 , —SOR 9 , —SOR 12 , —SO 2 R 9 , —SO 2 R 12 , —SO 2 CH(R 12 )(R 11 ), —OR 12 , —N(R 10 )(R 11 ), cyano, or aryl which is optionally substituted with —SO 2 R 12 ;

each D is independently C 1-3 alkyl, C 2-3 alkenyl, C 2-3 alkynyl, aryl, heteroaryl, C 3-8 cycloalkyl or heterocyclyl wherein each said aryl, heteroaryl, cycloalkyl and heterocyclyl groups, which may be monocyclic or bicyclic, is optionally substituted on either the carbon or the heteroatom with one to five substituents independently selected from C 1-6 alkyl, haloalkyl, halo, keto, alkoxy, —SR 9 , —SR 12 , —OR 9 , —OR 12 , N(R 12 ) 2 , —SO 2 R 9 , or —SO 2 R 10 ;

R 7 is hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 alkyloxy, halo, nitro, cyano, aryl, heteroaryl, C 3-8 cycloalkyl, heterocyclyl, —C(O)OR 10 , —C(O)OSi[CH(CH 3 ) 2 ] 3 , —OR 9 , —OR 10 , —C(O)R 10 , —R 10 C(O)R 9 , —C(O)R 9 , —C(O)N(R a )(R b ), —C(O)N(R 12 )(R 12 ), —C(O)N(R 10 )(R 11 ), —C(R 10 )(R 11 )OH, —SR 12 , —SR 9 , —R 10 SR 9 , —R 9 , —C(R 9 ) 3 , —C(R 10 )(R 11 )N(R 9 ) 2 , —NR 10 C(O)NR 10 S(O) 2 R 9 , —SO 2 R 12 , —SO(R 12 ), —SO 2 R 9 , —SO m N(R c )(R d ), —SO m CH(R 10 )(R 11 ), —SO 2 N(R 10 )C(O)(R 12 ), —SO 2 (R 10 )C(O)N(R 12 ) 2 , —OSO 2 R 10 , —N(R 10 )(R 11 ), —N(R 10 )C(O)N(R 10 )(R 9 ), N(R 10 )CO(R 9 ), —N(R 10 )C(O)R 10 , —N(R 10 )C(O)OR 10 , —N(R 10 )SO 2 (R 10 ), —C(R 10 )(R 11 )NR 10 C(R 10 )(R 11 )R 9 , —C(R 10 )(R 11 )N(R 10 )R 9 , —C(R 10 )(R 11 )N(R 10 )(R 11 ), —C(R 10 )(R 11 )SC(R 10 )(R 11 )(R 9 ), R 10 S—, —C(R a )(R b )NR a C(R a )(R b )(R 9 ), —C(R a )(R b )N(R a )(R b ), —C(R a )(R b )C(R a )(R b )N(R a )(R b ), —C(O)C(R a )(R b )N(R a )(R b ), —C(R a )(R b )N(R a )C(O)R 9 , —C(O)C(R a )(R b )S(R a ), C(R a )(R b )C(O)N(R a )(R b ), —B(OH) 2 , —OCH 2 O— or 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl;

wherein said groups are optionally substituted on either the carbon or the heteroatom with one to five substituents independently selected from C 1-6 alkyl, halo, keto, cyano, haloalkyl, hydroxyalkyl, —OR 9 , —NO 2 , —NH 2 , —NHS(O) 2 R 8 , —R 9 SO 2 R 12 , —SO 2 R 12 , —SO(R 12 ), —SR 12 , —SR 9 , —SO m N(R c )(R d ), —SO m N(R 10 )C(O)(R 12 ), —C(R 10 )(R 11 )N(R 10 )(R 11 ), —C(R 10 )(R 11 )OH, —COOH, —C(R a )(R b )C(O)N(R a )(R b ), —C(O)(R a )(R b ), —N(R 10 )C(R 10 )(R 11 )(R 9 ), —N(R 10 )CO(R 9 ), —NH(CH 2 ) 2 OH, —NHC(O)OR 10 , —Si(CH 3 ) 3 , heterocycyl, aryl or heteroaryl;

R 8 is hydrogen or C 1-6 alkyl;

or R 4 and R 8 or can be taken together with any of the atoms to which they may be attached or are between them to form a 4-10 membered heterocyclyl ring system wherein said ring system, which may be monocyclic or bicyclic, is optionally substituted with one or two substituents independently selected from C 1-6 alkyl, halo, hydroxyalkyl, hydroxy, keto, —OR 10 , —SR 10 or —N(R 10 ) 2 ;

R 9 is selected from the group consisting of hydrogen, aryl, aryl(C 1-4 )alkyl, heteroaryl, heteroaryl(C 1-4 )alkyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl(C 1-4 )alkyl, and heterocyclyl(C 1-4 )alkyl wherein said groups can be optionally substituted with one, two, or three substituents independently selected from halo, alkoxy or —SO 2 R 12 ;

R 10 is hydrogen or C 1-6 alkyl

R 11 is hydrogen or C 1-6 alkyl;

R 12 is hydrogen or C 1-6 alkyl which is optionally substituted with one, two, or three substituents independently selected from halo, alkoxy, cyano, —NR 10 or —SR 10 ;

R a is hydrogen, C 1-6 alkyl, (C 1-6 alkyl)aryl, (C 1-6 alkyl)hydroxyl, —O(C 1-6 alkyl), hydroxyl, halo, aryl, heteroaryl, C 3-8 cycloalkyl, heterocyclyl, wherein said alkyl, aryl, heteroaryl, C 3-8 cycloalkyl and heterocyclyl can be optionally substituted on either the carbon or the heteroatom with one, two, or three substituents independently selected from C 1-6 alkyl or halo;

R b is hydrogen, C 1-6 alkyl, (C 1-6 alkyl)aryl, (C 1-6 alkyl)hydroxyl, alkoxyl, hydroxyl, halo, aryl, heteroaryl, C 3-8 cycloalkyl, heterocyclyl, wherein said alkyl, aryl, heteroaryl, C 3-8 cycloalkyl and heterocyclyl can be optionally substituted on either the carbon or the heteroatom with one, two, or three substituents independently selected from C 1-6 alkyl or halo;

or R a and R b can be taken together with the carbon atom to which they are attached or are between them to form a C 3-8 cycloalkyl ring or C 3-8 heterocyclyl ring wherein said 3-8 membered ring system may be optionally substituted with one or two substituents independently selected from C 1-6 alkyl and halo;

R c is hydrogen or C 1-6 alkyl which is optionally substituted with one, two, or three substituents independently selected from halo or —OR 9 ;

R d is hydrogen or C 1-6 alkyl which is optionally substituted with one, two, or three substituents independently selected from halo or —OR 9 ;

or R c and R d can be taken together with the nitrogen atom to which they are attached or are between them to form a C 3-8 heterocyclyl ring which is optionally substituted with one or two substituents independently selected from C 1-6 alkyl, halo hydroxyalkyl, hydroxy, alkoxy or keto;

n is independently selected from an integer from one to three;

each m is independently selected from an integer from zero to two;

and the pharmaceutically acceptable salts and stereoisomers thereof.

17. The method of claim 15 wherein the compound is N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide or a pharmaceutically acceptable salt thereof.

18. The method of claim 16 wherein the compound is N 1 -(1-cyanocyclopropyl)-4-fluoro-N 2 -{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide or a pharmaceutically acceptable salt thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2016
From: BAYLY, CHRISTOPHER I.; BLACK, CAMERON; LEGER, SERGE; LI, CHUN SING; MCKAY, DAN; MELLON, CHRISTOPHE; GAUTHIER, JACQUES YVES; LAU, CHEUK; TRUONG, VOUY-LINH; THERIEN, MICHEL
To: MERCK FROSST CANADA & CO.
Reel/Frame 039155/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2016
From: GREEN, MICHAEL J.; HIRSCHBEIN, BERNARD L.; JANC, JAMES WILLIAM; PALMER, JAMES T.; BASKARAN, CHITRA
To: AXYS PHARMACEUTICALS, INC.
Reel/Frame 039156/0141 →
CHANGE OF NAME Recorded Jul 14, 2016
From: MERCK FROSST CANADA LTD.
To: MERCK CANADA INC.
Reel/Frame 039157/0313 →
Continuity (5)
Division 12082104 · Apr 8, 2008
Division 10505796
Provisional Application 60361818 · Mar 5, 2002
Provisional Application 60408704 · Sep 6, 2002
Related Publication 20110230446A1 · Sep 22, 2011